CALR and congenital heart block: In the event of a subsequent conception, hydroxychloroquine prophylaxis (400 mg/day) would be recommended starting preconceptionally or early in gestation, based on data demonstrating a reduction in recurrence of congenital heart block from approximately 18% to 7% in anti-Ro/SSA–positive women [40].